Neutra Corp. (NTRR) stock
NTRROTCMedicinal Chemicals & Botanical ProductsFiscal year ends January 31
Financials through Q3 FY2024, quarter ended Oct 31, 2023Last filing: 10-Q on Aug 7, 2024
$0.00+0.00 (0.00%)
Close on Oct 19, 2026Market cap –P/E –Yield –
Neutra price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Neutra's price to sales ratio was 16.8× on Oct 19, 2026, against 33.5× a year earlier. Over the last 5 years it ranged from 6.9× to 82.5×, with a median of 22.2×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Oct 19, 2026 | 16.8× | +0.0 |
| 2025 | Dec 31, 2025 | 16.8× | −16.8 |
| 2024 | Dec 31, 2024 | 33.5× | −16.8 |
| 2023 | Dec 29, 2023 | 50.3× | +41.2 |
| 2022 | Dec 30, 2022 | 9.2× | −26.9 |
| 2021 | Dec 31, 2021 | 36.0× | – |
See a number that looks wrong?